Springer Nature AG & Co. KGaA (“Springer Nature”) today raises its guidance for the 2025 fiscal year, reflecting its strong performance year to date. In the first six months of 2025, revenue increased to €926 million and adjusted operating profit to €241 million, representing underlying growth of 6% and 10% respectively.

Given the continued positive development across its business, the company now expects underlying¹ Group revenue to be in the range of €1,930 million to €1,960 million (previously: in the upper half of the range of €1,885 million to €1,935 million) and underlying¹ adjusted operating profit (AOP) to be in the range of €540 million to €560 million (previously: in the upper half of the range of €523 million to €546 million).  
 
The upward revision is driven by the strong development in the Research segment, where nearly all 2025 contract renewals have been completed and continued high submission volumes, particularly in Full Open Access journals, are driving above-market publication growth. The Health and Education segments continue to perform in line with their respective markets, and supporting the overall Group performance.

Springer Nature will release its results for the first half-year 2025 on August 13, 2025.  


¹ At 2025 constant FX rates and excluding scope effects; 1 EUR = 1.082 USD = 0.847 GBP = 163.8 JPY


---------------------------------------------
Contact:
Thomas Geisselhart
EVP Corporate Finance, Group Treasury & Investor Relations
tel +49 30 82787 5111
thomas.geisselhart@springernature.com
---------------------------------------------

Disclaimer
 
Forward-looking statements
This announcement contains forward-looking statements. These forward-looking statements can be identified by the use of forward looking terminology, including the terms "plans," "targets," "aims," "continues," "believes," "estimates," "anticipates," "expects," "intends," "may," "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company does not take any responsibility to update, review or revise any forward-looking statement contained in this announcement whether as a result of new information, future developments or otherwise, unless it is required to do so under mandatory law.
 
Use of alternative performance measures
This release includes certain financial measures not presented in accordance with IFRS, which may exclude items that are significant in understanding and assessing the Company’s financial results. These measures should not be considered in isolation or as an alternative to measures of profitability, liquidity or performance under IFRS. Regarding the definition of the alternative performance measure adjusted operating profit and underlying change, the Company refers to the corresponding definition on page 39 of the 2024 Annual Report under the headings “Key performance indicators” and “Other financial performance indicators”, which is available on the Company’s investor relations website.